跳至主要内容
临床试验/NCT01526317
NCT01526317已完成1 期

A Randomized, Open Label, Cross-over Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers

Yuhan Corporation1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2011年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
36
试验地点
1
主要终点
AUCtau

研究概览

简要总结

This clinical trial is designed to compare the pharmacokinetic characteristics of combination and separate administration of Crestor(Rosuvastatin) and Glucodown(Metformin SR). Also investigate drug interaction between separate and combination administration.

Total number of subjects is 36. 6 group(6 for 1 group), 3 period, consecutive 5 day administration, 10 days washout after 5th day of administration.

All subjects take Crestor alone, Glucodown alone, Crestor+Glucodown combination during 3 each period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 20~50 yrs old, healthy Korean Subjects
  • Body weight <ideal body weight±20%
  • No congenital, chronic disease, No current disease
  • Subjects who are diagnosed to include by medical doctor from laboratory and ECG result.
  • Subjects who agree to keep contraceptive methods during the clinical trial.

排除标准

  • Subjects who are allergic to investigational drug.
  • Subjects who have a medical history which can affect the clinical trial.
  • Hypertension(Systolic BP ≥ 150mmHG or Diastolic BP ≥ 100mmHg), Hypotension(Systolic BP ≤ 100mmHg or Diastolic BP ≤ 65mmHg)
  • Subjects who have taken other medicine in recent 2~4 weeks.
  • Subjects who have a risk of hypoglycemia and imbalance in taking a diet.

研究组 & 干预措施

1

Experimental

This arm is consist of 6 subject. Crestor 10mg and Glucodown 750mg for 5 day during period 1. Crestor 10mg alone for 5 day during period 2. Glucodown 750mg alone for 5 day during period 3.

干预措施: Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) (Drug)

2

Experimental

This arm is consist of 6 subject. Glucodown 750mg alone for 5 day during period 1. Crestor 10mg and Glucodown 750mg for 5 day during period 2. Crestor 10mg alone for 5 day during period 3.

干预措施: Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) (Drug)

3

Experimental

This arm is consist of 6 subject. Crestor 10mg alone for 5 day during period 1. Glucodown 750mg alone for 5 day during period 2. Crestor 10mg and Glucodown 750mg for 5 day during period 3.

干预措施: Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) (Drug)

4

Experimental

This arm is consist of 6 subject. Glucodown 750mg alone for 5 day during period 1. Crestor 10mg alone for 5 day during period 2. Crestor 10mg and Glucodown 750mg for 5 day during period 3.

干预措施: Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) (Drug)

5

Experimental

This arm is consist of 6 subject. Crestor 10mg alone for 5 day during period 1. Crestor 10mg and Glucodown 750mg for 5 day during period 2. Glucodown 750mg alone for 5 day during period 3.

干预措施: Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) (Drug)

6

Experimental

This arm is consist of 6 subject. Crestor 10mg and Glucodown 750mg for 5 day during period 1. Glucodown 750mg alone for 5 day during period 2. Crestor 10mg alone for 5 day during period 3.

干预措施: Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) (Drug)

结局指标

主要结局

AUCtau

时间窗: 72 hr

Css,max

时间窗: 72 hr

次要结局

  • AUCss,last(72 hr)
  • AUCss,inf(72 hr)
  • Css,min(72 hr)
  • Tss,max(72 hr)
  • t1/2(72 hr)

研究者

发起方
Yuhan Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Phase 1 Clinical Trial to Investigate... | 临床试验